Mesoblast LtdNASDAQ:MESO
- LAST PRICE6.8500
- TODAY'S CHANGE (%)0.2100 (3.1627%)
- Bid / Lots6.3000/ 1
- Ask / Lots6.9200/ 1
- Open / Previous Close6.7000 / 6.6400
- Day Range
- 52 Week Range
- Volume134,427
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MESO |
|---|---|---|
| 09:32 ET | 1128 | 6.73 |
| 09:34 ET | 600 | 6.74 |
| 09:36 ET | 1000 | 6.775 |
| 09:38 ET | 1500 | 6.84 |
| 09:39 ET | 2176 | 6.9 |
| 09:41 ET | 11645 | 6.88 |
| 09:43 ET | 200 | 6.88 |
| 09:45 ET | 1800 | 6.92 |
| 09:48 ET | 100 | 6.9 |
| 09:50 ET | 655 | 6.88 |
| 09:52 ET | 100 | 6.8958 |
| 09:54 ET | 3760 | 6.93 |
| 09:56 ET | 200 | 6.81 |
| 09:57 ET | 100 | 6.81 |
| 10:01 ET | 100 | 6.81 |
| 10:03 ET | 250 | 6.8 |
| 10:06 ET | 200 | 6.73 |
| 10:10 ET | 200 | 6.72 |
| 10:12 ET | 100 | 6.72 |
| 10:14 ET | 1652 | 6.7217 |
| 10:15 ET | 1400 | 6.78 |
| 10:17 ET | 100 | 6.78 |
| 10:21 ET | 166 | 6.78 |
| 10:26 ET | 718 | 6.79 |
| 10:28 ET | 3812 | 6.7446 |
| 10:30 ET | 1100 | 6.77 |
| 10:32 ET | 800 | 6.73 |
| 10:33 ET | 200 | 6.79 |
| 10:35 ET | 100 | 6.73 |
| 10:39 ET | 100 | 6.72 |
| 10:48 ET | 256 | 6.72 |
| 10:51 ET | 200 | 6.67 |
| 10:53 ET | 100 | 6.66 |
| 10:55 ET | 100 | 6.68 |
| 10:57 ET | 935 | 6.65 |
| 11:00 ET | 350 | 6.66 |
| 11:02 ET | 1200 | 6.73 |
| 11:04 ET | 200 | 6.7 |
| 11:08 ET | 340 | 6.7 |
| 11:11 ET | 344 | 6.7 |
| 11:15 ET | 200 | 6.7 |
| 11:20 ET | 200 | 6.7 |
| 11:26 ET | 400 | 6.7 |
| 11:27 ET | 100 | 6.7 |
| 11:33 ET | 400 | 6.7 |
| 11:42 ET | 200 | 6.68 |
| 11:44 ET | 100 | 6.69 |
| 11:47 ET | 2300 | 6.69 |
| 11:49 ET | 100 | 6.675 |
| 11:58 ET | 218 | 6.69 |
| 12:00 ET | 100 | 6.68 |
| 12:03 ET | 100 | 6.66 |
| 12:07 ET | 250 | 6.68 |
| 12:12 ET | 1363 | 6.66 |
| 12:14 ET | 200 | 6.7 |
| 12:21 ET | 300 | 6.71 |
| 12:23 ET | 300 | 6.68 |
| 12:27 ET | 100 | 6.66 |
| 12:32 ET | 358 | 6.67 |
| 12:34 ET | 100 | 6.7199 |
| 12:36 ET | 300 | 6.67 |
| 12:39 ET | 469 | 6.705 |
| 12:41 ET | 100 | 6.72 |
| 12:45 ET | 700 | 6.74 |
| 12:48 ET | 100 | 6.75 |
| 12:52 ET | 493 | 6.745 |
| 12:56 ET | 1100 | 6.76 |
| 12:57 ET | 400 | 6.76 |
| 12:59 ET | 200 | 6.77 |
| 01:01 ET | 2358 | 6.799 |
| 01:06 ET | 100 | 6.77 |
| 01:10 ET | 300 | 6.77 |
| 01:14 ET | 100 | 6.75 |
| 01:15 ET | 100 | 6.73 |
| 01:17 ET | 450 | 6.72 |
| 01:21 ET | 200 | 6.69 |
| 01:26 ET | 100 | 6.71 |
| 01:32 ET | 453 | 6.74 |
| 01:35 ET | 634 | 6.746 |
| 01:39 ET | 900 | 6.71 |
| 01:42 ET | 100 | 6.72 |
| 01:48 ET | 319 | 6.73 |
| 01:51 ET | 100 | 6.73 |
| 01:55 ET | 200 | 6.74 |
| 02:00 ET | 100 | 6.7 |
| 02:02 ET | 500 | 6.74 |
| 02:04 ET | 100 | 6.71 |
| 02:08 ET | 300 | 6.71 |
| 02:09 ET | 100 | 6.73 |
| 02:15 ET | 400 | 6.71 |
| 02:20 ET | 191 | 6.7 |
| 02:22 ET | 1201 | 6.76 |
| 02:24 ET | 100 | 6.76 |
| 02:27 ET | 200 | 6.75 |
| 02:31 ET | 574 | 6.755 |
| 02:33 ET | 100 | 6.76 |
| 02:36 ET | 300 | 6.75 |
| 02:42 ET | 300 | 6.75 |
| 02:44 ET | 1000 | 6.775 |
| 02:45 ET | 919 | 6.78 |
| 02:47 ET | 193 | 6.7709 |
| 02:49 ET | 300 | 6.8 |
| 02:51 ET | 1684 | 6.83 |
| 02:54 ET | 464 | 6.8223 |
| 02:58 ET | 729 | 6.8 |
| 03:02 ET | 400 | 6.79 |
| 03:03 ET | 200 | 6.79 |
| 03:05 ET | 572 | 6.77 |
| 03:09 ET | 400 | 6.76 |
| 03:12 ET | 140 | 6.7601 |
| 03:14 ET | 482 | 6.77 |
| 03:16 ET | 100 | 6.77 |
| 03:18 ET | 502 | 6.78 |
| 03:20 ET | 500 | 6.77 |
| 03:23 ET | 845 | 6.78 |
| 03:25 ET | 321 | 6.78 |
| 03:30 ET | 175 | 6.775 |
| 03:32 ET | 150 | 6.77 |
| 03:34 ET | 1529 | 6.78 |
| 03:36 ET | 100 | 6.8 |
| 03:39 ET | 952 | 6.78 |
| 03:41 ET | 503 | 6.78 |
| 03:43 ET | 1715 | 6.795 |
| 03:45 ET | 516 | 6.78 |
| 03:50 ET | 200 | 6.76 |
| 03:52 ET | 2531 | 6.785 |
| 03:54 ET | 101 | 6.78 |
| 03:56 ET | 1811 | 6.81 |
| 03:57 ET | 2103 | 6.79 |
| 03:59 ET | 3005 | 6.85 |
Jun 2, 2024
Mesoblast Corporate Presentation at Investor Conference, from 8:23PM ET on Sunday Jun 02, 2024 by Dow Jones
8:23PM ET on Sunday Jun 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mesoblast Ltd | 736.0M | -4.7x | --- |
Stoke Therapeutics Inc | 727.1M | -5.5x | --- |
Nuvation Bio Inc | 739.0M | -9.7x | --- |
Immunome Inc | 721.4M | -2.2x | --- |
SS Innovations International Inc | 683.0M | -32.1x | --- |
89Bio Inc | 719.2M | -3.8x | --- |
Company Information
Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.
Contact Information
- Headquarters
- L 38 55 Collins StMELBOURNE, VIC, Australia 3000
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Jane Bell
- Chief Executive Officer, Executive Director
- Silviu Itescu
- Non-Executive Independent Vice Chairman of the Board
- William Burns
- Interim Chief Financial Officer
- Andrew Chaponnel
- Chief Operating Officer
- Dagmar Rosa-Bjorkeson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $736.0M |
|---|---|
Revenue (TTM) | $7.5M |
Shares Outstanding | 114.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.47 |
EPS | $-1.44 |
Book Value | $12.34 |
P/E Ratio | -4.7x |
Price/Sales (TTM) | 98.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -735.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
